322 related articles for article (PubMed ID: 31730913)
1. Systemic delivery of microRNA-21 antisense oligonucleotides to the brain using T7-peptide decorated exosomes.
Kim G; Kim M; Lee Y; Byun JW; Hwang DW; Lee M
J Control Release; 2020 Jan; 317():273-281. PubMed ID: 31730913
[TBL] [Abstract][Full Text] [Related]
2. Delivery of High Mobility Group Box-1 siRNA Using Brain-Targeting Exosomes for Ischemic Stroke Therapy.
Kim M; Kim G; Hwang DW; Lee M
J Biomed Nanotechnol; 2019 Dec; 15(12):2401-2412. PubMed ID: 31748020
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-specific anti-RAGE exosomes for nose-to-brain delivery of anti-miR-181a oligonucleotide in an ischemic stroke model.
Kim M; Lee Y; Lee M
Nanoscale; 2021 Sep; 13(33):14166-14178. PubMed ID: 34477698
[TBL] [Abstract][Full Text] [Related]
4. Antisense-oligonucleotide co-micelles with tumor targeting peptides elicit therapeutic effects by inhibiting microRNA-21 in the glioblastoma animal models.
Lee Y; Ha J; Kim M; Kang S; Kang M; Lee M
J Adv Res; 2023 Nov; 53():249-260. PubMed ID: 36632887
[TBL] [Abstract][Full Text] [Related]
5. Brain-targeted exosome-mimetic cell membrane nanovesicles with therapeutic oligonucleotides elicit anti-tumor effects in glioblastoma animal models.
Lee Y; Kim M; Ha J; Lee M
Bioeng Transl Med; 2023 Mar; 8(2):e10426. PubMed ID: 36925699
[TBL] [Abstract][Full Text] [Related]
6. T7 peptide-decorated exosome-based nanocarrier system for delivery of Galectin-9 siRNA to stimulate macrophage repolarization in glioblastoma.
Li C; Guan N; Liu F
J Neurooncol; 2023 Mar; 162(1):93-108. PubMed ID: 36854924
[TBL] [Abstract][Full Text] [Related]
7. Engineering exosomes for pulmonary delivery of peptides and drugs to inflammatory lung cells by inhalation.
Kim G; Lee Y; Ha J; Han S; Lee M
J Control Release; 2021 Feb; 330():684-695. PubMed ID: 33388343
[TBL] [Abstract][Full Text] [Related]
8. Anti-cancer effect of R3V6 peptide-mediated delivery of an anti-microRNA-21 antisense-oligodeoxynucleotide in a glioblastoma animal model.
Oh B; Song H; Lee D; Oh J; Kim G; Ihm SH; Lee M
J Drug Target; 2017 Feb; 25(2):132-139. PubMed ID: 27355932
[TBL] [Abstract][Full Text] [Related]
9. Engineered exosomes mediated targeted delivery of neuroprotective peptide NR2B9c for the treatment of traumatic brain injury.
Haroon K; Zheng H; Wu S; Liu Z; Tang Y; Yang GY; Liu Y; Zhang Z
Int J Pharm; 2024 Jan; 649():123656. PubMed ID: 38040392
[TBL] [Abstract][Full Text] [Related]
10. Kill two birds with one stone: Engineered exosome-mediated delivery of cholesterol modified YY1-siRNA enhances chemoradiotherapy sensitivity of glioblastoma.
Liu X; Cao Z; Liu N; Gao G; Du M; Wang Y; Cheng B; Zhu M; Jia B; Pan L; Zhang W; Jiang Y; He W; Xu L; Zhang W; An Q; Guo Q; Gu J
Front Pharmacol; 2022; 13():975291. PubMed ID: 36059990
[TBL] [Abstract][Full Text] [Related]
11. Delivery of anti-microRNA-21 antisense-oligodeoxynucleotide using amphiphilic peptides for glioblastoma gene therapy.
Song H; Oh B; Choi M; Oh J; Lee M
J Drug Target; 2015 May; 23(4):360-70. PubMed ID: 25572456
[TBL] [Abstract][Full Text] [Related]
12. Cardiac-specific delivery by cardiac tissue-targeting peptide-expressing exosomes.
Kim H; Yun N; Mun D; Kang JY; Lee SH; Park H; Park H; Joung B
Biochem Biophys Res Commun; 2018 May; 499(4):803-808. PubMed ID: 29621543
[TBL] [Abstract][Full Text] [Related]
13. A curcumin-loaded polymeric micelle as a carrier of a microRNA-21 antisense-oligonucleotide for enhanced anti-tumor effects in a glioblastoma animal model.
Tan X; Kim G; Lee D; Oh J; Kim M; Piao C; Lee J; Lee MS; Jeong JH; Lee M
Biomater Sci; 2018 Jan; 6(2):407-417. PubMed ID: 29340361
[TBL] [Abstract][Full Text] [Related]
14. Targeting and Therapy of Glioblastoma in a Mouse Model Using Exosomes Derived From Natural Killer Cells.
Zhu L; Oh JM; Gangadaran P; Kalimuthu S; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
Front Immunol; 2018; 9():824. PubMed ID: 29740437
[TBL] [Abstract][Full Text] [Related]
15. Delivery of Anti-miRNA-221 for Colorectal Carcinoma Therapy Using Modified Cord Blood Mesenchymal Stem Cells-Derived Exosomes.
Han S; Li G; Jia M; Zhao Y; He C; Huang M; Jiang L; Wu M; Yang J; Ji X; Liu X; Chen C; Chu X
Front Mol Biosci; 2021; 8():743013. PubMed ID: 34616773
[No Abstract] [Full Text] [Related]
16. Exosome-Mediated miR-29 Transfer Reduces Muscle Atrophy and Kidney Fibrosis in Mice.
Wang H; Wang B; Zhang A; Hassounah F; Seow Y; Wood M; Ma F; Klein JD; Price SR; Wang XH
Mol Ther; 2019 Mar; 27(3):571-583. PubMed ID: 30711446
[TBL] [Abstract][Full Text] [Related]
17. RVG-modified exosomes derived from mesenchymal stem cells rescue memory deficits by regulating inflammatory responses in a mouse model of Alzheimer's disease.
Cui GH; Guo HD; Li H; Zhai Y; Gong ZB; Wu J; Liu JS; Dong YR; Hou SX; Liu JR
Immun Ageing; 2019; 16():10. PubMed ID: 31114624
[TBL] [Abstract][Full Text] [Related]
18. Exosomes of bone-marrow stromal cells inhibit cardiomyocyte apoptosis under ischemic and hypoxic conditions via miR-486-5p targeting the PTEN/PI3K/AKT signaling pathway.
Sun XH; Wang X; Zhang Y; Hui J
Thromb Res; 2019 May; 177():23-32. PubMed ID: 30844685
[TBL] [Abstract][Full Text] [Related]
19. The use of antibody modified liposomes loaded with AMO-1 to deliver oligonucleotides to ischemic myocardium for arrhythmia therapy.
Liu M; Li M; Sun S; Li B; Du D; Sun J; Cao F; Li H; Jia F; Wang T; Chang N; Yu H; Wang Q; Peng H
Biomaterials; 2014 Apr; 35(11):3697-707. PubMed ID: 24468403
[TBL] [Abstract][Full Text] [Related]
20. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes.
Alvarez-Erviti L; Seow Y; Yin H; Betts C; Lakhal S; Wood MJ
Nat Biotechnol; 2011 Apr; 29(4):341-5. PubMed ID: 21423189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
